Join ERDERA’s extended webinar on the Joint Transnational Call on 14 January

blank

Following the success of our previous session, ERDERA warmly invites researchers, patient advocates, and early-career professionals to an extended webinar on 14 January 2025. This webinar is part of the 2025 Joint Transnational Call for Proposals, “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”, which was officially launched on 10 December 2024.

Clickhere to register for the webinar.

This Webinar will:

  • Inform applicants about lessons learned about the evaluation.
  • Guide applicants with key translational, regulatory, data managing, and methodological considerations for drafting strong pre-proposals.
  • Address your questions through dedicated Q&A sessions.

Agenda (CET)

  • 14.00-14.10 Introduction (Ralph Schuster)
  • 14.10-14.20 Lessons learned from previous callsevaluators perspective
    (ChristineKinnon)
  • 14.20-14.30 Q&A Round 1
  • 14.30-14.45 Innovating Management Toolbox (IMT) and Mentoring service (Agustin Arasanz Duque, Rosan Kreeftmeijer-Vegter, Toni Andreu)
  • 14.45-15.00 Regulatory Support Service (Viviana Giannuzzi, David Morrow)
  • 15.00-15.10 Q&A Round 2
  • 15.10-15.25 Methodological Support (Rima Nabbout)
  • 15.25-15.40 Data standards and FAIRification (Marco Roos)
  • 15.40-15.50 Q&A Round 3
  • 15.50-16.00 Closing remarks  

Registration is mandatory

  • The registration deadline is14 January 2025.
  • Upon submitting your registration, you will receive connection links and calendar invitations to ensure seamless participation.

Note:The webinar will be recorded, and the video recording will be made availableexclusively to registered participants.

Don’t miss this chance to get ahead in the application process and ensure that your project stands out!

Find out more details about ERDERA’s Joint Transnational Call 2025 – Announcementhere.

News & Updates

You might also be interested in

The 2026 Open Academy x ERDERA Schools in Barcelona brought patient advocates and early-career researchers together for practical training on medicines development, translational research and meaningful participation in rare disease research.
ERDERA will launch its Clinical Trial Call 2026 (ECTC) on 1 July 2026, supporting multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.
Pre-announcement describing scope, eligibility and indicative timeline for the ERDERA Clinical Trial Call 2026, expected to open on 1 July 2026.